Navigation Links
John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technology's Potential to Help 'Millions of Patients'
Date:8/13/2008

Best-Selling Author to Devote Energies to Raising Awareness and Funds to Advance the Use of Focused Ultrasound in Treating Cancers, Neurological,

Other Serious Medical Conditions

CHARLOTTESVILLE, Va., Aug. 13 /PRNewswire/ -- The Focused Ultrasound Surgery Foundation, founded in 2006 to accelerate the development and adoption of a breakthrough therapeutic technology -- Magnetic Resonance Guided Focused Ultrasound Surgery -- is pleased to announce that author John Grisham has been elected to the Board of Directors for a three-year term.

Dr. Neal F. Kassell, Professor of Neurosurgery at the University of Virginia and Chairman of the Foundation's Board, announced the election and added, "We are delighted to have John as a Board member. It shows that the promise of this technology is attracting prominent support even beyond the scientific and medical community." Mr. Grisham's role will be two-fold: first, to help obtain the philanthropic support necessary to accelerate the development of this exciting field; and, secondly, to increase the awareness of this innovative therapeutic approach.

Mr. Grisham, author of 21 best sellers and a resident of Charlottesville, Virginia, said, "My medical knowledge is quite limited; however, I am convinced that this technology will soon touch the lives of millions of patients, and I am thrilled to have the opportunity to be part of this effort."

About Magnetic Resonance Guided Focused Ultrasound (MRgFUS)

MRgFUS is a disruptive technology that is poised to revolutionize the treatment of a wide variety of medical disorders by serving as the ultimate in minimally invasive surgery; an alternative to radiation therapy; the means for precisely delivering drugs in high concentrations to the point where they are needed, avoiding systemic toxicity; and, dissolving blood clots and restoring circulation.

MRgFUS holds the potential to non-invasively treat breast, prostate, liver, and other benign and malignant tumors; to convert metastatic cancer from a lethal disease to a manageable, chronic disorder; reverse the disabling and life threatening neurological deficits from stroke; to alleviate the symptoms of Parkinson's disease, epilepsy, and chronic pain; and to address a host of other disorders ranging from heart disease to diabetes.

The procedure can be performed on an outpatient basis, does not require general anesthesia or incisions, results in minimal discomfort and few complications, and allows rapid recovery.

MRgFUS is the result of the integration of two technologies: high intensity focused ultrasound and magnetic resonance imaging. Focused ultrasound technology uses multiple intersecting beams of ultrasound energy focused with extreme precision on a target as small as one millimeter in diameter. Where each individual ultrasound beam passes through the tissue there is no effect, but where they intersect in the body, the focused energy creates a cumulative effect, enabling precise ablation of tissue, highly targeted drug delivery, or liquification of blood clots. Magnetic resonance imaging is used to visualize normal anatomy and abnormal structures within the body, to localize the tissue to be targeted, to guide and control the treatment interactively, and to evaluate the effectiveness of therapy.

About The Focused Ultrasound Surgery Foundation (FUSF) http://www.fusfoundation.org

The Charlottesville based Focused Ultrasound Surgery Foundation's mission is to shorten the time from technology development to patient treatment, to develop new applications, and to accelerate the worldwide adoption of MRgFUS. The Foundation's activities include: funding translational and clinical research, providing fellowships for training physicians and scientists, hosting symposia and workshops, maintaining online informational resources, and establishing new centers of excellence.

Contact

Sara Nazzaro

Feinstein Kean Healthcare

(617) 761-6742

sara.nazzaro@fkhealth.com


'/>"/>
SOURCE Focused Ultrasound Surgery Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
3. Hank Plain Joins Morgenthaler Ventures as Partner
4. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
5. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
6. Dan Broderick Joins Prolog Ventures as Partner
7. Ingenuity Systems Joins Biomarkers Consortium
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
10. Progeniq Joins Microsoft in Bio IT Alliance
11. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), ... Therapeutics Inc. (NASDAQ: BIND ). Learn more about ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016 The ... has awarded the 44 million US Dollar project, for ... Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... leader in the production and implementation of Identity Management Solutions. ... January, however Decatur was selected for ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
Breaking Biology News(10 mins):